• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
COVID-19 Testing

What is the Probability of a False Negative When Taking a SARS-CoV-2 Test?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Kucirka et al. (Annals of Internal Medicine, 2020) estimated the false negative rate of SARS-CoV-2 RT-PCR tests by day since infection

METHODS:

  • Literature review and pooled analysis
  • Data derived from 7 studies
    • SARS-CoV-2 RT-PCR test information that included time since symptom onset
  • Participants
    • A mix of inpatients and outpatients with SARS-CoV-2 infection
  • Study design
    • Samples derived from the upper respiratory tract
    • Bayesian modeling was used to estimate the false-negative rate of SARS-CoV-2 tests by day since exposure and symptom onset
    • Exposure assumed to have occurred 5 days before symptom onset based on previous studies

RESULTS:

  • Data on 1,330 respiratory tract samples were obtained from the 7 studies
  • The highest probability of a false-negative result was 1 day after exposure, and decreased through day 8 (3 days after symptom onset), before increasing again
    • On day 1: 100% (95% CI, 100% to 100%)
    • On day 4: 67% (95% CI, 27% to 94%)
    • On day 5 (symptom onset): 38% (95% CI, 18% to 65%)
    • On day 8 (3 days after symptom onset): 20% (95% CI, 12% to 30%)
    • On day 9: 21% (95% CI, 13% to 31%)
    • On day 21: 66% (95% CI, 54% to 77%)

CONCLUSION:

  • Highest probability for a false negative COVID-19 RT-PCR test
    • Early in the course of SARS-CoV-2 infection (prior to symptoms)
  • Lowest probability for a false negative COVID-19 RT-PCR test
    • 8 days after exposure (3 days after symptom onset)
  • Study limits
    • Estimates are imprecise due to the heterogeneity in the included studies’ designs
    • Generally, studies included cases with ≥1 positive RT-PCR result | Therefore, patients who were infected but never tested positive would not be included and could result in an underestimation of the true false-negative rate
  • The authors caution to be very careful interpreting negative results and provide the following suggestions

If clinical suspicion is high, infection should not be ruled out on the basis of RT-PCR alone, and the clinical and epidemiologic situation should be carefully considered

Clinicians should consider waiting 1 to 3 days after symptom onset to minimize the probability of a false-negative result

Further studies to characterize test performance and research into higher-sensitivity approaches are critical

Learn More – Primary Sources:

Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure

Get COVID-19 Research Summaries Direct to Your Phone, with ObGFirst

Try it Free  »

image_pdfFavoriteLoadingFavorite
< Previous
All COVID-19 Testing Posts
Next >

Related ObG Topics:

What is the Data Behind the Use of Saliva Samples for COVID-19 Testing?
Universal Screening: What Percent of Women Admitted to L&D are Positive for SARS-CoV-2?
Further Evidence for a 5 Day COVID-19 Incubation Period

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site